Participation in a randomized phase III study (evaluating the role of adjuvant docetaxel in high-risk breast cancer patients) improves treatment strategies and individual patient care in recruiting centers: The ADEBAR-Trial.
Document type:
Meeting Abstract
Author(s):
Janni, W; Sommer, H; Rack, B; Steinfeld, D; Augustin, D; Heinrigs, M; Gauger, K; Kiechle, M; Harbeck, N; Friese, K